Iclaprim structure
|
Common Name | Iclaprim | ||
---|---|---|---|---|
CAS Number | 192314-93-5 | Molecular Weight | 354.403 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 616.7±65.0 °C at 760 mmHg | |
Molecular Formula | C19H22N4O3 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 326.8±34.3 °C |
Use of IclaprimIclaprim is a new selective bacterial Dihydrofolate inhibitor, which can inhibit the growth of S. aureus (MRSA) with an MIC90 of 0.06 mg/mL. |
Name | iclaprim |
---|---|
Synonym | More Synonyms |
Description | Iclaprim is a new selective bacterial Dihydrofolate inhibitor, which can inhibit the growth of S. aureus (MRSA) with an MIC90 of 0.06 mg/mL. |
---|---|
Related Catalog | |
Target |
Dihydrofolate[1] |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 616.7±65.0 °C at 760 mmHg |
Molecular Formula | C19H22N4O3 |
Molecular Weight | 354.403 |
Flash Point | 326.8±34.3 °C |
Exact Mass | 354.169189 |
PSA | 105.51000 |
LogP | 2.20 |
Vapour Pressure | 0.0±1.8 mmHg at 25°C |
Index of Refraction | 1.666 |
Storage condition | 2-8℃ |
Iclaprim |
2,4-Pyrimidinediamine, 5-[(2-cyclopropyl-7,8-dimethoxy-2H-1-benzopyran-5-yl)methyl]- |
5-[(2-cyclopropyl-7,8-dimethoxy-2h-chromen-5-yl)methyl]pyrimidine-2,4-diamine |
5-[(2-Cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl)methyl]-2,4-pyrimidinediamine |